Loyal is a biotech startup developing the first drugs intended to help dogs live longer, healthier lives. By targeting the underlying mechanisms of aging, Loyal hopes to extend the lifespan of dogs and maintain their quality of life as they age.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/21/24 | $45,000,000 | Series B |
Bain Capital Ventures Box Group Collaborative Fund First Round Capital Quiet Capital Valor Equity Partners | undisclosed |
